Brock Scientific Consulting, 19909 Hamil Cir., Montgomery Village, MD, 20886, USA.
Int J Toxicol. 2010 Dec;29(6):582-93. doi: 10.1177/1091581810384154. Epub 2010 Oct 19.
This study consisted of a 28-day oral repeat dose (repeat dose toxicity [RDT]) phase and a developmental and reproductive (developmental and reproductive toxicity [DART]) phase with rats. Rats were treated with Dechlorane Plus at doses of 0, 750, 1500, or 5000 mg/kg by gavage. For the RDT phase, no effects were observed on in-life parameters or clinical or anatomic pathology. In the DART phase, no effects were observed on reproductive or fertility indices, or fetal development through lactation day (LD) 4. No effects were noted on gestation day (GD) 20 implantation data, fetal indices, or external and visceral examinations. Mortalities occurred across all dose groups, although these were gavage-related errors and not compound related. Microscopic evidence of gavage-related errors included adhesions, inflammation, and fibrosis in the thoracic and pleural cavities. These findings were not test article related as they were observed only in animals with evidence of gavage injury. The no-observable-effect level (NOEL) in both phases of study was 5000 mg/kg.
这项研究包括 28 天的口服重复剂量(重复剂量毒性[RDT])阶段和大鼠的发育和生殖(发育和生殖毒性[DART])阶段。大鼠通过灌胃接受 Dechlorane Plus 的剂量分别为 0、750、1500 或 5000mg/kg。在 RDT 阶段,在生存参数或临床或解剖病理学方面未观察到任何影响。在 DART 阶段,在生殖或生育指数或通过哺乳期第 4 天(LD)的胎儿发育方面未观察到任何影响。在妊娠第 20 天的植入数据、胎儿指数或外部和内脏检查方面也未观察到任何影响。所有剂量组均发生死亡,尽管这些是与灌胃相关的错误,而与化合物无关。与灌胃相关的错误的显微镜证据包括胸腔和胸膜腔中的粘连、炎症和纤维化。这些发现与试验物质无关,因为仅在有灌胃损伤证据的动物中观察到这些发现。在研究的两个阶段,无可见效应水平(NOEL)均为 5000mg/kg。